As procurement fraud enforcement continues to be a priority for the Department of Justice and other federal agencies, we take a look back at significant 2025 enforcement developments affecting government contractors, grant recipients and participants in federal programs in our 2025 Procurement Fraud Review.
Continue Reading Procurement Fraud Enforcement Trends Continue Into 2026In a recent article for Law360, I examined the significant challenges the Department of Justice (DOJ) may face as it seeks to use the False Claims Act (FCA) to pursue allegedly unlawful diversity, equity, and inclusion (DEI) practices.
Continue Reading Legal Hurdles in Using FCA to Challenge DEI ProgramsSkin substitutes, bioengineered or natural materials designed to promote healing by replacing or supporting damaged skin, have become a key component of advanced wound care. But the significant Medicare reimbursement of these products commanded over the last few years has made them a prime target for enforcement by the Department of Justice and the Department of Health and Human Services Office of Inspector General (OIG).
Continue Reading Federal Court Seizes $2 Million from Wound Care Clinic: What Providers, Distributors, and Manufacturers Need to KnowI provided insight for Law360 on the government’s recent settlement with IBM to settle allegations into the company’s diversity, equity and inclusion (DEI) practices. The IBM deal is the first of its kind involving a company and alleged violations of the False Claims Act related to DEI practices. The article suggests this deal may signal the Department of Justice’s (DOJ) focus on enforcement actions involving DEI and the potential fines incurred.
Continue Reading Takeaways from IBM’s DEI SettlementIn 2025, the Department of Justice’s National Health Care Fraud Takedown led to criminal charges against 324 defendants and $14.6 billion in intended losses.
Continue Reading Genetic Testing Fraud: Why CMS and DOJ Are Increasing ScrutinyI recently provided insight for a Modern Healthcare article that examines the Department of Justice’s (DOJ) increased healthcare fraud enforcement efforts and growing use of artificial intelligence (AI) and data analytics in civil investigations. While whistleblower complaints continue to account for a substantial share of False Claims Act recoveries, the article highlights how enforcement agencies are increasingly using technology to identify billing outliers and support government-initiated investigations.
Continue Reading DOJ’s Expanding Healthcare Fraud Enforcement EffortsI recently participated in a panel discussion at the Federal Bar Association’s 2026 Qui Tam Conference focused on “‘Illegal DEI’ as an FCA Trigger.” We explored the scope of False Claims Act (FCA) enforcement under the Department of Justice’s (DOJ) Civil Rights Fraud Initiative and recent executive actions addressing “illegal DEI [diversity, equity and inclusion].” In addition to law firm attorneys, our panel included a speaker from the DOJ.
Continue Reading Insight on “Illegal DEI” as FCA Trigger at Federal Bar Association’s Qui Tam Conference
Bass, Berry & Sims released its 14th Annual Healthcare Fraud & Abuse Review in mid-February. As a companion to the Review, hosted a complimentary webinar, which provided an overview and discussion of key focus areas covered in the Review.
Continue Reading Watch Now | Healthcare Fraud & Abuse Annual Review WebinarThe federal government’s growing use of the False Claims Act (FCA) to pursue customs fraud signals a new era of trade enforcement, with importers facing heightened scrutiny and increased risk of whistleblower actions.
Continue Reading Cracking Down on Customs Fraud: How the False Claims Act Raises the Stakes for ImportersTIn one of its largest coordinated enforcement efforts to date, the Department of Justice recently announced charges against more than 300 defendants in connection with alleged healthcare fraud schemes.
Continue Reading Exploring the DOJ’s Use of AI in Healthcare Fraud Enforcement